CompletedPhase 3NCT04308590
A Study of the Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas
Studying OBSOLETE: Cushing syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Corcept Therapeutics
- Principal Investigator
- Andreas Moraitis, MDCorcept Therapeutics
- Intervention
- Relacorilant(drug)
- Enrollment
- 137 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2020 – 2024
Study locations (30)
- Site 27, Birmingham, Alabama, United States
- Site 17, Stanford, California, United States
- Site 53, Torrance, California, United States
- Site 07, Atlanta, Georgia, United States
- Site 16, Indianapolis, Indiana, United States
- Site 09, Metairie, Louisiana, United States
- Site 36, Baltimore, Maryland, United States
- Site 11, Fall River, Massachusetts, United States
- Site 33, Rochester, Minnesota, United States
- Site 06, Jackson, Mississippi, United States
- Site 54, Reno, Nevada, United States
- Site 10, Jamaica, New York, United States
- Site 44, New York, New York, United States
- Site 01, Wilmington, North Carolina, United States
- Site 30, Cleveland, Ohio, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04308590 on ClinicalTrials.govOther trials for OBSOLETE: Cushing syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07296484Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)Sparrow Pharmaceuticals
- RECRUITINGNCT07156370Salivary Cortisol and Hypercortisolism in Type 2 DiabetesShanghai 6th People's Hospital
- RECRUITINGPHASE1, PHASE2NCT07350707Diagnostic Value of CXCR4-targeted PET/CT in ACTH-dependent and Independent Cushing's SyndromePeking Union Medical College Hospital
- ACTIVE NOT RECRUITINGNANCT05315388Effects of "Vitamin N" Nature Immersion Therapy on Stress Levels in Health Care Workers in the City of BogotáJeadran N. Malagón-Rojas
- ACTIVE NOT RECRUITINGNCT05382156Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's SyndromeRECORDATI GROUP
- RECRUITINGNANCT05368090Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary AldosteronismHaukeland University Hospital